Results: 26

Afibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion

Arq. bras. oftalmol; 86 (1), 2023
ABSTRACT Purpose: To evaluate the effectiveness of intravitreal aflibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion. Methods: Thirty-seven eyes with branch retinal vein occlusion treated with intravitreal aflibercept injection for macu...

Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion

Arq. bras. oftalmol; 86 (1), 2023
ABSTRACT Purpose: To investigate the effects of epiretinal membrane formation on the clinical outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion. Methods: This retrospective interventional case series includes the treatment of naive patients...

Protocolo assistencial de injeções intravítreas do HCPA: edema macular diabético

Clin. biomed. res; 42 (2), 2022
RESUMO: O edema macular diabético é uma das principais causas de baixa visual no mundo e a indicação mais frequente de injeções intravítreas no Hospital de Clínicas de Porto Alegre. O tratamento com injeção intra-vítrea de medicamentos anti-vascular endothelial growth factor, incluindo o bevac...

Unilateral intravitreal dexamethasone implant for the treatment of cystoid macular edema in intermediate uveitis

Rev. bras. oftalmol; 80 (2), 2021
ABSTRACT This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis. Bearing in mind the adverse effects of the prolonged use of systemic corticosteroids, th...

Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results

Arq. bras. oftalmol; 83 (5), 2020
ABSTRACT Purpose: To compare the efficacy of three initial monthly intravitreal aflibercept injections followed by pro re nata (3+PRN) dosing versus five initial monthly intravitreal aflibercept injections followed by pro re nata (5+PRN) dosing in patients with diabetic macular edema. Methods: A total ...

Changes in the ganglion cell complex thickness after anti-VEGF treatment for diabetic macular edema

Arq. bras. oftalmol; 83 (5), 2020
ABSTRACT Purpose: To assess tomographic ganglion cell complex changes in patients with diabetic macular edema treated with intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF). Methods: We analyzed data from 35 eyes of 35 previously untreated patients in whom diabetic macular ...

Dexamethasone intravitreal implant for macular edema: a pilot study in a public health center

ABCS health sci; 45 (Supl. 3), 2020
INTRODUCTION: Macula edema consists in one of the most common causes of visual impairment. OBJECTIVE: To evaluate the safety and efficacy of continuous release of 0.7 mg dexamethasone (using implantable device) for treatment of macular edema. METHODS: Cross-sectional observational study of 16 patients tr...

Regression of macular edema with topical brinzolamide and nepafenac alone and identification of a novel gyrate atrophy mutation

Arq. bras. oftalmol; 83 (2), 2020
ABSTRACT Gyrate atrophy is a rare metabolic autosomal recessive disorder caused by ornithine aminotransferase enzyme deficiency that leads to characteristic progressive, degenerative chorioretinal findings. Patients complain mostly of low vision, night blindness, and peripheral vision loss. Posterior sub...

Optical coherence tomography angiography findings in patients with branch retinal vein occlusion treated with Anti-VEGF

Arq. bras. oftalmol; 83 (2), 2020
ABSTRACT Purpose: To investigate retinal microvasculature changes in patients treated with anti-VEGF for macular edema secondary to branch retinal vein occlusion. Methods: We examined 38 eyes of 19 patients for the study. We measured superficial and deep capillary plexus vessel densities (%), foveal av...

Unilateral intravitreal dexamethasone implant for diabetic macular edema: effect in the contralateral eye

Arq. bras. oftalmol; 83 (1), 2020
ABSTRACT We describe three patients who had previous heart diseases and nonproliferative diabetic retinopathy with clinically significant diabetic macular edema. They underwent unilateral dexamethasone intravitreal implantation. Without ophthalmological treatment in the fellow eye, patients showed marked...